Diabetic nephropathy

M. E. Molitch; R. A. DeFronzo; M. J. Franz; W. F. Keane; C. E. Mogensen; H. H. Parving; M. W. Steffes

doi:10.2337/diacare.21.1.s50

Diabetic nephropathy

M. E. Molitch, R. A. DeFronzo, M. J. Franz, W. F. Keane, C. E. Mogensen, H. H. Parving, M. W. Steffes

Laboratory Medicine and Pathology

Research output: Contribution to journal › Review article › peer-review

62 Scopus citations

Abstract

Annual screening for microalbuminuria will allow the identification of patients with nephropathy at a point very early in its course. Improving glycemic control, aggressive antihypertensive treatment, and the use of AGE inhibitors will slow the rate of progression of nephropathy. In addition, protein restriction and other treatment modalities such as phosphate lowering may have benefits in selected patients.

Original language	English (US)
Pages (from-to)	S50-S53
Journal	Diabetes care
Volume	21
Issue number	SUPPL. 1
DOIs	https://doi.org/10.2337/diacare.21.1.s50
State	Published - Jan 1998

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access

10.2337/diacare.21.1.s50

OpenUrl availability

Full text

Cite this

@article{b79c2b8fbeb8496c978423b829f705ec,

title = "Diabetic nephropathy",

abstract = "Annual screening for microalbuminuria will allow the identification of patients with nephropathy at a point very early in its course. Improving glycemic control, aggressive antihypertensive treatment, and the use of AGE inhibitors will slow the rate of progression of nephropathy. In addition, protein restriction and other treatment modalities such as phosphate lowering may have benefits in selected patients.",

author = "Molitch, {M. E.} and DeFronzo, {R. A.} and Franz, {M. J.} and Keane, {W. F.} and Mogensen, {C. E.} and Parving, {H. H.} and Steffes, {M. W.}",

year = "1998",

month = jan,

doi = "10.2337/diacare.21.1.s50",

language = "English (US)",

volume = "21",

pages = "S50--S53",

journal = "Diabetes care",

issn = "0149-5992",

publisher = "American Diabetes Association Inc.",

number = "SUPPL. 1",

}

TY - JOUR

T1 - Diabetic nephropathy

AU - Molitch, M. E.

AU - DeFronzo, R. A.

AU - Franz, M. J.

AU - Keane, W. F.

AU - Mogensen, C. E.

AU - Parving, H. H.

AU - Steffes, M. W.

PY - 1998/1

Y1 - 1998/1

N2 - Annual screening for microalbuminuria will allow the identification of patients with nephropathy at a point very early in its course. Improving glycemic control, aggressive antihypertensive treatment, and the use of AGE inhibitors will slow the rate of progression of nephropathy. In addition, protein restriction and other treatment modalities such as phosphate lowering may have benefits in selected patients.

AB - Annual screening for microalbuminuria will allow the identification of patients with nephropathy at a point very early in its course. Improving glycemic control, aggressive antihypertensive treatment, and the use of AGE inhibitors will slow the rate of progression of nephropathy. In addition, protein restriction and other treatment modalities such as phosphate lowering may have benefits in selected patients.

UR - http://www.scopus.com/inward/record.url?scp=0031985190&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031985190&partnerID=8YFLogxK

U2 - 10.2337/diacare.21.1.s50

DO - 10.2337/diacare.21.1.s50

M3 - Review article

AN - SCOPUS:0031985190

SN - 0149-5992

VL - 21

SP - S50-S53

JO - Diabetes care

JF - Diabetes care

IS - SUPPL. 1

ER -

Diabetic nephropathy

Abstract

UN SDGs

Access

OpenUrl availability

Other files and links

Fingerprint

Cite this